

What You Can't See: Understanding Invisible Disability
This week, October 18th to 24th, marks Invisible Disabilities Awareness Week. When we think of disability, we often imagine wheelchairs, casts or another visible cue. But not every disease comes with a visible sign; there may not be an obvious sign telling the world that someone is fighting hard to get through the day. Pulmonary Hypertension (PH) is a prime example. On the surface, a person living with PH may look completely healthy, but inside, their heart and lungs are fi


Mosliciguat PHocus study succeeds, and other pharma news
PHocus study succeeds The PHocus study, a Phase 2 trial evaluating the safety and effectiveness of the new drug mosliciguat for pulmonary hypertension associated with interstitial lung disease. (PH-ILD), reported good results. After 16 weeks of taking mosliciguat, participants’ pulmonary vascular resistance dropped by over half, their six-minute walk distance increased by 35m, and their NTproBNP level also dropped by half. Based on these very encouraging results, Pulmovant be


What do blood clots have to do with pulmonary hypertension?
October 13 is World Thrombosis Day A thrombosis is a blood clot inside a blood vessel, and October 13 is World Thrombosis Day, a global campaign to raise awareness of blood clots and their risk factors. This year’s campaign highlights women’s blood clot risks throughout life, including those associated with hormonal changes, pregnancy, and menopause. Blood clots can have serious consequences, including pulmonary embolism, which occurs when a clot blocks blood flow in the lung



.jpg)

















